Therapeutic mechanisms of ginseng in coronary heart disease

MM Tang, ST Zhao, RQ Li, W Hou - Frontiers in Pharmacology, 2023 - frontiersin.org
Coronary heart disease (CHD) is the most common clinical manifestation of cardiovascular
disease. It is characterized by myocardial ischemia, which is caused by coronary …

Elevated plasma factor XI predicts cardiovascular events in patients with type 2 diabetes: a long-term observational study

E Paszek, M Polak, AH Bryk-Wiązania… - Cardiovascular …, 2023 - Springer
Background Type 2 diabetes mellitus (T2DM) patients are at high risk of cardiovascular (CV)
events. Factor XI (FXI) is associated with arterial thromboembolism, including myocardial …

Neutrophil extracellular traps (NETs) in cardiovascular diseases: From molecular mechanisms to therapeutic interventions

J Natorska, M Ząbczyk, A Undas - Polish Heart Journal …, 2023 - journals.viamedica.pl
Neutrophil extracellular traps (NETs), which are net-like structures composed of DNA,
histones, and antimicrobial proteins, in particular myeloperoxidase (MPO) and elastase …

Danshen-Shanzha formula for the treatment of atherosclerosis: ethnopharmacological relevance, preparation methods, chemical constituents, pharmacokinetic …

Q Xu, Z Yu, M Zhang, T Feng, F Song, H Tang… - Frontiers in …, 2024 - frontiersin.org
Danshen-Shanzha Formula (DSF) is a well-known herbal combination comprising Radix
Salvia Miltiorrhiza (known as Danshen in Chinese) and Fructus Crataegi (known as …

[PDF][PDF] Blood clot properties, thrombin generation and platelet activation in patients with dysglycemia and established atherosclerotic cardiovascular disease: The …

A Siniarski, R Gołębiowska-Wiatrak… - Polish Heart …, 2024 - journals.viamedica.pl
Background: There is a strong link between both coronary artery disease (CAD), type 2
diabetes (T2D) and altered fibrin clot properties, including increased clot density, and …

Elevated factor XI is associated with increased risk of recurrent cerebral venous sinus thrombosis: a cohort study

E Paszek, M Polak, A Undas - Journal of Thrombosis and Thrombolysis, 2024 - Springer
Cerebral venous sinus thrombosis (CVST) has no identified cause in 15% of cases.
Elevated factors (F) VIII and FXI have been associated with thromboembolism, but data on …

Bibliometric analysis of residual cardiovascular risk: trends and frontiers

L Wang, S Wang, C Song, Y Yu, Y Jiang… - Journal of Health …, 2023 - Springer
Background The presence of residual cardiovascular risk is an important cause of
cardiovascular events. Despite the significant advances in our understanding of residual …